Novel encapsulation technology for oral delivery
Freund Pharmatec
Hot Topics > Bioavailability Challenge
Bioavailability Challenge
Drug industry demand for ways of improving drug bioavailability is increasing as industry development pipelines fill with BCS Class II and IV compounds.
in-Pharmatechnologist.com will host "Bioavailability Challenge 2013" a free to attend virtual event where you can discuss the latest scientific breakthroughs with experts and meet with fellow researchers and industry peers.
Sign up for the free, virtual event here .
Deeper than ever bio images thanks to new nanotech
01-Oct-2012 - Drug delivery developers could get a boost from a new nanoparticle that can provide deep-tissue imaging.
Hovione adds particle design capabilities to API offering
27-Sep-2012 - API maker Hovione has added particle design to its drug delivery and formulation development offering citing pharma demand.
Could oral testosterone replacement therapy come in a capsule?
26-Sep-2012 - Clarus Therapeutics believes it has solved the oral availability problem for testosterone replacement therapy.
PRACS Institute sells Miami facility to CRI Phase I
29-Aug-2012 - The PRACS Institute has sold its Miami, US facility to a new early-phase focused CRO, CRI Phase I Corporation.
BE/BA sites must be logged with US FDA under GDUFA
28-Aug-2012 - Bioequivalence and bioavailability (BE/BA) studies for generics firms will have to log details of their sites with the US FDA under new ‘self-identification’ rules.
BE/BA sites must be logged with US FDA under GDUFA
28-Aug-2012 - CROs conducting bioequivalence and bioavailability (BE/BA) studies for generics firms will have to log details of their sites with the US FDA under new ‘self-identification’ rules.
FDA to develop GDUFA self-identification database; warns about ANDA backlog fee
27-Aug-2012 - The US FDA plans to establish a new database for manufacturing facilities required to ‘self-identify’ under new GDUFA laws.
Capsugel wants to standardise lipid formulation tests
22-Aug-2012 - Capsugel has launched a non-profit consortium in a bid to establish a lipid formulation classification system.
Capsugel wants to standardise lipid formulation tests
22-Aug-2012 - Capsugel has launched a non-profit consortium in a bid to establish a lipid formulation classification system.
Quotient & Capsugel partner on lipid formulation services
26-Jun-2012 - Quotient and Capsugel have teamed up to tackle drug delivery challenges in lipid-based formulations with new assessment and development services.
Is drug delivery by skin the solution to bioavailability woes? report from Achema
21-Jun-2012 - Drug regulators and the biomanufacturing industry need to embrace drug delivery via the skin to solve solubility problems with peptides and proteins, according to Across Barriers’ Udo Bock.
P-Gels mean cheaper and more varied drug development, says Patheon
31-May-2012 - Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.
BASF renames solubilisation and dermatology excipients
12-Apr-2012 - BASF has developed a new naming scheme for the solubilisation and dermatology excipients it gained with the acquisition of Cognis .
Catalent and BASF team up to solve the bioavailability problem
05-Apr-2012 - Catalent and BASF have joined forces to tackle bioavailability challenges from feasibility studies to commercial supply.
Pharma must improve existing methods to boost solubility as “quantum leap” unlikely
15-Nov-2011 - To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.
BASF talks excipients, raw materials and development plans at CPhI 2011
31-Oct-2011 - BASF says solubility and bioavailability will be key focus for its pharmaceutical excipient product development efforts in the next few years.
Pii eyes gelatin shell evolution to enhance oral drug delivery
26-Oct-2011 - Pii is developing small intestine targeting drug delivery technologies as part of a focus on gelatin shell materials.
News in brief
Pii adds trial scale HME capacity
28-Jul-2011 - Pharmaceutics International (Pii) has expanded its range of formulation and process development services with the addition of bioavailability boosting hot-melt extrusion (HME) capabilities.
DCGI suspends Axis Clinicals’ research license
28-Jun-2011 - India’s DCGI has banned CRO Axis Clinicals from conducting bio-availability and bio-equivalence studies at its facility in Miyapur, Hyderabad.
Most Popular News
Key Industry Events
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference
Access all events listing
Products
On demand Supplier Webinars
Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
ATMI Life Science
